Alimera Sciences Stock Five Year Return
Alimera Sciences fundamentals help investors to digest information that contributes to Alimera Sciences' financial success or failures. It also enables traders to predict the movement of Alimera Stock. The fundamental analysis module provides a way to measure Alimera Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alimera Sciences stock.
Alimera |
Alimera Sciences Company Five Year Return Analysis
Alimera Sciences' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
CompetitionAccording to the company disclosure, Alimera Sciences has a Five Year Return of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
All Next | Launch Module |
Alimera Fundamentals
Return On Equity | -0.35 | |||
Return On Asset | 0.0098 | |||
Profit Margin | (0.15) % | |||
Operating Margin | 0.08 % | |||
Current Valuation | 360.44 M | |||
Shares Outstanding | 54.38 M | |||
Shares Owned By Insiders | 5.34 % | |||
Shares Owned By Institutions | 86.54 % | |||
Number Of Shares Shorted | 578.49 K | |||
Price To Earning | 1.65 X | |||
Price To Book | 7.77 X | |||
Price To Sales | 3.02 X | |||
Revenue | 80.75 M | |||
Gross Profit | 52 M | |||
EBITDA | 7.28 M | |||
Net Income | (20.13 M) | |||
Cash And Equivalents | 7.86 M | |||
Cash Per Share | 1.12 X | |||
Total Debt | 67.4 M | |||
Current Ratio | 1.30 X | |||
Book Value Per Share | 0.74 X | |||
Cash Flow From Operations | (14.26 M) | |||
Short Ratio | 1.93 X | |||
Earnings Per Share | 1.05 X | |||
Target Price | 5.67 | |||
Number Of Employees | 154 | |||
Beta | 1.25 | |||
Market Capitalization | 301.29 M | |||
Total Asset | 153.52 M | |||
Retained Earnings | (418.49 M) | |||
Working Capital | 30.51 M | |||
Current Asset | 51.6 M | |||
Current Liabilities | 7.85 M | |||
Net Asset | 153.52 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |